Cargando...
The β(3)‐adrenoceptor agonist mirabegron increases human atrial force through β(1)‐adrenoceptors: an indirect mechanism?
BACKGROUND AND PURPOSE: Mirabegron has been classified as a β(3)‐adrenoceptor agonist approved for overactive bladder syndrome. We investigated possible cardiac effects of mirabegron in the absence or presence of β‐adrenoceptor subtype antagonists. In view of its phenylethanolamine structure, we inv...
Gardado en:
| Publicado en: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522995/ https://ncbi.nlm.nih.gov/pubmed/28574581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13897 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|